• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 234-248 of 276 results

2037 Exhibit: Ex2037 Xalatan Label

Document IPR2017-01434, No. 2037 Exhibit - Ex2037 Xalatan Label (P.T.A.B. Mar. 5, 2018)

cite Cite Document

1035 Exhibit: US Patent No 5,296,504 to Stjernschantz et al, issued March 22, 199...

Document IPR2017-01434, No. 1035 Exhibit - US Patent No 5,296,504 to Stjernschantz et al, issued March 22, 1994 (P.T.A.B. Jun. 5, 2018)

cite Cite Document

1053 Exhibit: Santen Pharmaceutical Co, Ltd Annual Report 2013

Document IPR2017-01434, No. 1053 Exhibit - Santen Pharmaceutical Co, Ltd Annual Report 2013 (P.T.A.B. Jun. 5, 2018)

cite Cite Document

2030 Exhibit: Ex2030 Santen Financial Results

Document IPR2017-01434, No. 2030 Exhibit - Ex2030 Santen Financial Results (P.T.A.B. Mar. 5, 2018)

cite Cite Document

2024 Exhibit: Ex2024 Lee 1985

Document IPR2017-01434, No. 2024 Exhibit - Ex2024 Lee 1985 (P.T.A.B. Mar. 5, 2018)

cite Cite Document

2023 Exhibit: Ex2023 USP 5977173

Document IPR2017-01434, No. 2023 Exhibit - Ex2023 USP 5977173 (P.T.A.B. Mar. 5, 2018)

cite Cite Document

2060 Exhibit: Ex 2060 Xalatan label, Nov 26, 2001

Document IPR2017-01434, No. 2060 Exhibit - Ex 2060 Xalatan label, Nov 26, 2001 (P.T.A.B. Jul. 26, 2018)

cite Cite Document

2064 Exhibit: Ex 2064 Human Metabolome Database latanoprost replacement for E...

Document IPR2017-01434, No. 2064 Exhibit - Ex 2064 Human Metabolome Database latanoprost replacement for Ex 2057 (P.T.A.B. Jul. 26, 2018)

cite Cite Document

1001 Exhibit: Exhibit 1001 US Patent No 5,886,035 to Shirasawa et al

Document IPR2017-01434, No. 1001 Exhibit - Exhibit 1001 US Patent No 5,886,035 to Shirasawa et al (P.T.A.B. May. 12, 2017)

cite Cite Document

2063 Exhibit: Ex 2063 Human Metabolome Database tafluprost replacement for Ex...

Document IPR2017-01434, No. 2063 Exhibit - Ex 2063 Human Metabolome Database tafluprost replacement for Ex 2056 (P.T.A.B. Jul. 26, 2018)

cite Cite Document

1046 Exhibit: Husain S et al, ¿¿¿Latanoprost Induced Changes in Rat IntraocularPre...

Document IPR2017-01434, No. 1046 Exhibit - Husain S et al, ¿¿¿Latanoprost Induced Changes in Rat IntraocularPressure Direct or Indirect ¿¿¿ J Ocul Pharmacol Ther, 244367¿¿¿372 2008 (P.T.A.B. Jun. 5, 20...

cite Cite Document

1045 Exhibit: Patel SS et al, ¿¿¿Latanoprost A Review of its Pharmacological Proper...

Document IPR2017-01434, No. 1045 Exhibit - Patel SS et al, ¿¿¿Latanoprost A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability in the Management of Primary Open Angle Glaucom...

cite Cite Document

2061 Exhibit: Ex 2061 deLong Transcript II

Document IPR2017-01434, No. 2061 Exhibit - Ex 2061 deLong Transcript II (P.T.A.B. Jul. 26, 2018)

cite Cite Document

2054 Exhibit: Ex 2054 Tapros Drug Information Sheet

Document IPR2017-01434, No. 2054 Exhibit - Ex 2054 Tapros Drug Information Sheet (P.T.A.B. Aug. 9, 2018)

cite Cite Document

1048 Exhibit: Skuballa W et al, ¿¿¿15, 15 Ketals of NaturalProstaglandins and Prosta...

Document IPR2017-01434, No. 1048 Exhibit - Skuballa W et al, ¿¿¿15, 15 Ketals of NaturalProstaglandins and Prostaglandin Analogues Synthesis and Biological Activities,¿¿¿ J Med Chem 21443¿¿¿447 1978 ...

cite Cite Document
<< 1 2 3 4 5 ... 16 17 18 19 >>